Head of Department of Vaccines & Diagnostics
Moredun Research Institute

Dr Stew Burgess is the Head of the Vaccines and Diagnostics Department at the Moredun Research Institute, Edinburgh. He also leads the sheep scab research group, which focuses on developing novel tools for the control of sheep scab, caused by skin infestation with the sheep scab mite, Psoroptes ovis. Recent developments include a commercially available sheep scab blood test, which can detect infested animals before the appearance of clinical signs and also the first prototype sheep scab vaccine, which significantly reduces mite numbers and the size of the skin lesions, offering a more sustainable method of scab control in the future. Stew also leads several sheep scab control programmes across the UK, including the Rural Development Programme England (RDPE)-funded sheep scab control programme in England, a Biotechnology and Biological Sciences Research Council (BBSRC)-funded control programme in Northern Ireland and a Scottish Government-funded control programme on the Western Isles of Lewis & Harris.

Other speakers

Sven Arnouts Business Development Manager Ghent University - Provaxs
Klaus Hellmann Head of EU-CRO Argenta
Johannes Charlier Managing Director Kreavet
Nathalie Vanderheijden Coordinator fot the European Partnership on Animal Health and Welfare Ghent University
Laetitia Cicchelero Cross-Health platform coordinator - Provaxs University of Ghent
Hervé Poulet Director of Strategic Partnering Boehringer Ingelheim
Sebastiaan Theuns CEO & co-founder PathoSense
Dieter Vancraeynest External Innovation Zoetis
Beatrice Vos Partner Stonehaven Cozmix Group (SC Group)
Bryan Charleston Director and CEO The Pirbright Institute
Inne Xhonneux Project Advisor Life Sciences Flanders Innovation & Entrepreneurship (VLAIO)
Kazuhiko Hirose President and Representative Director Meiji Animal Health Co., Ltd.
Juerg Baggenstoss Partner Stonehaven Cozmix Group
Paul Dick Founder and President Paul Dick and Associates
Steve Nanchen Head External Innovation - R&D Elanco Animal Health
Erwin Blomsma CEO and Co-Founder Benno Therapeutics
Alfonso Martín-Fontecha Business Development Manager Laboratorios SYVA
Valerio Abbadessa Research Programme Officer EC DG AGRI, F2 R&I
Paul Horwood UK Head of Farm & Exports IVC Evidensia
Daisy Vanrompay Director of the Laboratory of Immunology and Animal Biotechnology Ghent University
Jennifer Serriere-Di Bartolo Biopharma Strategic Collaboration & Marketing Manager Promega
Jens Radzimanowski Director of Antibody Therapeutics Lead Identification Boehringer Ingelheim
Pieter-Jan Serreyn Technical Director AnimalhealthEurope
Charles Owen Founder and CEO 272Bio Limited
Jeremy Gowler Chief Executive Officer Ophirex, Inc.
Ivo Claassen Deputy Executive Director - Head of Veterinary Medicines Division European Medicines Agency
Jeroen Hofenk Founder & CSO SwiftPharma
Ashiqul Haque Chief scientific officer Quantoom Biosciences
Xiao Shen CEO Canton Biologics
Paweł Wielgus Member of the Management Board Bioceltix
Bert Devriendt Professor Ghent University
Endre Kiss-Tóth Founder, CEO StemcellX Limited
Edwin Veldhuizen Assistant professor Utrecht University, Faculty of Veterinary Medicine
Bing Han Lead High Tech Animal Models Wageningen Bioveterinary Research (WBVR)
Francisco LePort CEO Gordian Biotechnology
Anniek Eerdekens Postdoctoral Researcher Ghent University – WAVES/Imec
Saci Iken Business Development Manager Univercells Technologies
Thomas Robert Senior Innovation & Scientific Affairs Lead Univercells Technologies
Joni Bert Researcher Ghent University
Ulrike Diesterbeck Managing Director, Chief Scientific Officer VEROVACCiNES GmbH
Benedict Chambers CEO Prodessa Pharmceuticals
Natacha Gaillard and Ashwani Sharma Co-CEOs ASTRA Therapeutics AG
Nicolas Galmarini Co-Founder & CEO Nanogrow Biotech
Konrad Szczukiewicz Co-founder, Board Member VET CELL TECH
Ralf Herold Head of Regulatory Science and Academia, Task force Regulatory Science and Innovation, EMA European Medicines Agency
Ronaldo Avella Lavado Business Development, Operations and Regulatory Affairs Manager Paul Dick & Associates Ltd.